Abstract
Bullous pemphigoid (BP) is an autoimmune blistering skin disorder. Recently, BP induced by dipeptidyl peptidase-4 (DPP-4) inhibitors has been a concern. Although DPP-4 inhibitors are commonly used in the Asian population because of their safety and efficacy, BP associated with DPP-4 inhibitors is sometimes seen in clinical settings. Here, we report five Japanese cases of BP associated with the agents. In the present cases, BP occurred in older adults using four different DPP-4 inhibitors, which showed various clinical manifestations in terms of latency period for BP, sex, glycemic control and diabetes duration. Withdrawal of DPP-4 inhibitors was effective in improving BP, and achieved remission even in cases requiring oral steroid administration and intravenous immunoglobulin therapy. Clinicians should note the importance of early diagnosis of this clinical condition and initiate prompt withdrawal of DPP-4 inhibitors.
References
May 1, 1989·The Journal of Clinical Investigation·J R Stanley
Jun 27, 1998·Clinics in Dermatology·S Vassileva
Oct 25, 2011·Diabetes Research and Clinical Practice·Yi-Ming MuKevin E K Tan
Apr 1, 2016·The British Journal of Dermatology·J BénéUNKNOWN French Association of Regional PharmacoVigilance Centres
May 19, 2016·Journal of Clinical Pharmacy and Therapeutics·M GarcíaC Aguirre
Oct 25, 2016·The Journal of Investigative Dermatology·Kentaro IzumiHiroshi Shimizu
Sep 7, 2016·Geriatrics & Gerontology International·Taro KojimaUNKNOWN Working Group on Guidelines for Medical Treatment and its Safety in the Elderly
Oct 8, 2016·The British Journal of Dermatology·A SakaiR Abe
Jan 6, 2017·Journal of Diabetes Investigation
Citations
Feb 16, 2018·The Journal of Dermatology·Nobuki MakiToshio Demitsu
Oct 27, 2018·American Journal of Clinical Dermatology·Patrick M JedlowskiMaryam T Fazel
Feb 15, 2019·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Remi KoderaAtsushi Araki
Oct 15, 2018·Postgraduate Medical Journal·Ankur GulianiDavinder Parsad
Apr 17, 2019·Journal of Diabetes Investigation·Takaaki MurakamiNobuya Inagaki
Oct 13, 2019·International Journal of Dermatology·Alejandra ReolidEsteban Daudén
Oct 2, 2019·BMJ Case Reports·Hariharasudan ManiAdedayo A Onitilo
Aug 3, 2020·Diabetes/metabolism Research and Reviews·Wenjia YangLinong Ji
Jun 9, 2018·Frontiers in Immunology·Olivier GaudinCatherine Prost-Squarcioni
Jul 6, 2019·Frontiers in Immunology·Kaisa TasanenWataru Nishie
Oct 15, 2020·Biomolecules·Francesco MoroGiovanni Di Zenzo
Nov 2, 2020·Experimental Dermatology·Payal M PatelKyle T Amber
May 1, 2021·Journal of Clinical Medicine·Ágnes KinyóRolland Gyulai
May 25, 2021·Experimental Dermatology·Lula María Nieto-BenitoRicardo Suárez-Fernández
May 18, 2021·Journal of Diabetes Investigation·Tomonori SekizakiTatsuya Atsumi
Sep 25, 2021·Journal of Diabetes Investigation·Hirohito KuwataTomoaki Imamura